HomeInvestors HealthAltimmune spikes after presenting data for obesity drug

Altimmune spikes after presenting data for obesity drug

525-5250815_gold-ball-free-png-gold-ball-png-clipart

September 10, 2024

Altimmune spikes after presenting data for obesity drug

Source link

Previous article

Mama’s Creations GAAP EPS of $0.03 beats by $0.01, revenue of $28.38M beats by $0.24M (NASDAQ:MAMA)

Next article

Evolution Petroleum Non-GAAP EPS of $0.03 misses by $0.01, revenue of $21.23M misses by $2.49M

Investors Health Image

latest articles

explore more

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here